This link on the FDA web site seems to say that the clo-sur pad is not FDA aproved for use with arteral sheath removeal "In addition, a September 9, 2002, press release found at http://www.scioncv.com/PressReleases.html, entitled "Scion Cardio-Vascular Announces Agreement With Medtronic For Distribution Of The Clo-Sur P.A.D., An Innovative Device Used For Rapid Bleeding Control After Catheterization," states that the device is used for rapid control of bleeding associated with all vascular access sites. The press release refers to use of the device for the rapid control of bleeding associated with catheter removal following a catheterization procedure such as coronary stenting, as well as other minimally invasive procedures. For the more than 5.8 million Americans each year who undergo angioplasties, cardiac catheterizations, PTCA, stenting and other minimally invasive procedures, the Clo-Sur P.A.D. represents a dramatic step forward in the healing process. These materials suggest that this topical device can be used following a catheterization lab procedure to achieve closure of the arterial puncture site. Such uses are not included within the cleared intended uses for hydrophilic wound dressings. We invite you submit a 510(k) to support the use of the Clo-Sur P.A.D.™ for closure of the femaral artery site; however, in the absence of 510(k) clearance fur this use, your promotion of the Clo-Sur P.A.D.™ for this use creates a new inEnded use for this device that is not cleared by the FDA." http://www.fda.gov/foi/warning_letters/g4147d.htm This was noted in Jul 2003. perhaps it is ok to use the device now for sheath removal.